Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results.

Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

A Santoro
Membro del Collaboration Group
;
2021-01-01

Abstract

Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results.
2021
Inglese
148
190
201
12
Adjuvant chemotherapy
Colon cancer
Compliance
Older patients
Oxaliplatin
Prognostic factors
Gerardo, Rosati; Sara, Lonardi; Fabio, Galli; Maria, Di Bartolomeo; Monica, Ronzoni; Maria G, Zampino; Maria, Banzi; Alberto, Zaniboni; Felice, Pasini...espandi
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
143
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/65397
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact